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Amphipathic helix, which senses membrane curvature, is of growing interest. Here we explore the
effect of amino acid distribution of amphipathic helical peptide derived from the C-terminal region
(residues 220–241) of human apolipoprotein (apo) A-I on membrane curvature sensing. This peptide
preferred a curved membrane in a manner similar to full-length apoA-I, although its model peptide
did not sense membrane curvature. Substitution of several residues both on the polar and non-polar
faces of the amphipathic helix had no signiﬁcant effect on sensing, suggestive of the elaborate
molecular architecture in the C-terminal helical region of apoA-I to exert lipid efﬂux function.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cellular membrane morphology has been assumed to control
the function and structure of membrane-associated proteins. In
particular, membrane curvature has recently been considered to
determine protein localization and trafﬁcking spatially and tempo-
rally in the cell [1]. Many proteins have been found not simply to
interact with the membrane but instead to sense membrane curva-
ture [2], wherein amphipathic helices, a structural motif for mem-
brane binding proteins, are also involved in membrane curvature
sensing [3].
Human apolipoprotein (apo) A-I is composed of a tandem re-
peat of amphipathic a-helices, each of which is characterized by
a speciﬁc charge distribution, with positively charged amino acid
residues at the polar/non-polar interface and negatively charged
residues at the center of the polar face [4]. ApoA-I plays a centralrole in high-density lipoprotein (HDL) generation, in which choles-
terol and phospholipid are transferred from cell membranes by the
action of ATP-binding cassette transporter A1 (ABCA1); however,
the detailed mechanisms of lipid efﬂux remain largely elusive.
ABCA1 is proposed to induce membrane bending (curvature)
through its lipid translocase activity. Full-length apoA-I molecule
has been shown to bind to a curved membrane surface, but not
to a ﬂat surface [5]. Thus, the highly curved membrane surface pro-
motes high-afﬁnity binding of apoA-I, leading to the spontaneous
solubilization of membrane lipids to generate HDL particles. The
C-terminal amphipathic region (corresponding to residues 220–
241) of apoA-I is crucial not only for lipid binding but also for lipid
efﬂux [6]. In the present study, to reveal how apoA-I recognizes a
curved membrane surface, we focused on the amino acid distribu-
tion of the C-terminal peptide derived from apoA-I. To this end,
binding preferences to small (curved) and large (ﬂat) phospholipid
vesicles were examined using apoA-I peptide and its model pep-
tide (18A peptide) with amino acid substitution of several residues.
2. Materials and methods
2.1. Materials
Fmoc amino acid derivatives were obtained from the Peptide
Institute, Inc. (Minoh, Japan) and used without further puriﬁcation.
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(St. Louis, MO), and stored in a nitrogen atmosphere at 20 C.
All other reagents were special or peptide synthesis grade.
2.2. Peptide synthesis
Sequences of the synthetic peptides used in the present study
and their helical wheel representations are depicted in Table 1
and Fig. 1, respectively. Hydrophobicity hHi and hydrophobic mo-
ment hlHi were obtained using HeliQuest (Table 1) [7]. 18A pep-
tide has been designed to possess a secondary structural motif of
a-helices in apoA-I [8]. Peptides were synthesized by the solid-
phase method with Fmoc chemistry [9]. N- and C-termini were
capped with an acetyl group and an amide group, respectively.
Peptides were puriﬁed by high-performance liquid chromatogra-
phy and their molecular masses ascertained by matrix-assisted la-
ser desorption ionization mass spectrometry (Voyager-DE PRO;
Applied Biosystems) (Table 1). In all experiments, peptides were
freshly dialyzed from 6 M guanidine hydrochloride solution into
10 mM sodium phosphate buffer (pH 7.4) before use. Peptide con-
centrations were determined by the Lowry procedure using bovine
serum albumin (Bio-Rad, Hercules, CA) as a standard. Single Trp
residue was incorporated into apoA-I 220–241 peptide at the posi-
tion of Phe225 (F225W) as the ﬂuorescent probe, which has been
veriﬁed to have no inﬂuences on the lipid-binding ability [9].
2.3. Preparation of lipid vesicles
A ﬁlm of egg PC on the wall of a glass tube was dried under vac-
uum overnight and hydrated with phosphate buffer. Egg PC small
unilamellar vesicles (SUV) were prepared by sonication and then
ultracentrifuged in a Beckman TLA110 rotor (51000 rpm) for 2 h.
Large unilamellar vesicles (LUV) were prepared by the extrusion
method through 100 nm pore ﬁlters. The average particle diame-
ters determined by quasi-elastic light scattering measurements
using a Photal FPAR-1000 particle analyzer (Otsuka Electronics
Co., Hirakata, Japan) were 130 ± 20 and 30 ± 3 nm for LUV and
SUV, respectively. The PC concentration was determined using an
enzymatic assay kit for choline from Wako (Osaka, Japan).
2.4. Fluorescence spectroscopy
Fluorescence measurements were carried out at 25 C using a
Hitachi F-7000 spectrophotometer (Tokyo, Japan). Emission spectra
of Trp were recorded in a 4  4 mm cuvette from 300 to 420 nm at
the excitationwavelengthof 295 nmwith increasing concentrations
of vesicles. To reduce the effect of light scatting, polarizers (excita-
tion and emission polarization set to horizontal and vertical, respec-
tively)were used as described [10]. Peptide and lipid concentrations
were 10 and 800 lM (excess amount), respectively.
2.5. Circular dichroism (CD) spectroscopy
CD spectra were recorded from 195 to 250 nm using an Aviv
62ADS spectropolarimeter (Lakewood, NJ). Peptide samplesTable 1
Amino acid sequence, molecular mass, and helix property of synthetic peptides.
Peptide Sequence
apoA-I 220–241/F225W Ac-PVLESWKVSFLSALEEYTKKLN-NH2
EKEK Ac-PVLEEWKVKFLEALEEYKKKLN-NH2
LL Ac-PVLESWKVSLLSALEELTKKLN-NH2
18A Ac-DWLKAFYDKVAEKLKEAF-NH2
4S Ac-DWLKAFYSSVAEKLSSAF-NH2
4F Ac-DWFKAFYDKVAEKFKEAF-NH2(10 lM) were prepared either in 10 mM sodium phosphate buffer
(pH 7.4) or in the presence of lipid vesicles (800 lM). Molar resid-
ual ellipticities ([h]) and the a-helix contents were calculated as
described [11].
2.6. Isothermal titration calorimetry (ITC)
Enthalpies of peptide binding to lipid vesicles were measured
using a MicroCal MCS isothermal titration calorimeter at 25 C as
described [11]. Measurements were carried out by titrating 8 ll
aliquots of apoA-I peptide (0.25 or 0.5 mg/ml) into the cell
(1.35 ml) containing lipid vesicles (15 mM) at constant time inter-
vals of 270 s. Under these experimental conditions, the lipid is al-
ways in excess over the peptide. In general, determination of
binding afﬁnities is done by titrating lipid vesicles into peptide
solution to gradually reduce the free peptide in the cell, which is
not necessary to measure binding enthalpies. Enthalpies of peptide
binding to lipid vesicles were corrected for the heat of the peptide
dilution and dissociation; these values were determined by titrat-
ing the peptide into buffer alone.
3. Results and discussion
3.1. Membrane curvature sensing of the C-terminal peptide of apoA-I
in comparison with its model 18A peptide
To test whether the C-terminal peptide derived from apoA-I
(apoA-I 220–241/F225W peptide) shows membrane curvature
sensing, Trp ﬂuorescence were measured in the absence and
presence of either SUV or LUV (Fig. 2A and C). In the lipid-free
state, the wavelength of maximum ﬂuorescence (WMF) of the
peptide was around 350 nm. Addition of SUV caused a large in-
crease in ﬂuorescence intensity accompanied by a blue shift in
the emission maximum, suggestive of the transfer of Trp residue
into the membrane environment. In contrast, no spectral
changes were observed by the addition of LUV. Furthermore,
CD measurements also exhibited such preferences to SUV with
a signiﬁcant increase in a-helical contents upon binding
(Fig. 3C). We additionally tested the effect of vesicle size with
intermediate average diameters of 85 ± 8 nm, showing no appar-
ent binding of apoA-I 220–241/F225W peptide (data not shown),
similar to LUV. These results suggest that only the C-terminal re-
gion essential for lipid binding is sufﬁcient for apoA-I molecule
to exert membrane curvature sensing.
On the other hand, 18A peptide, which is designed to mimic
apoA-I amphipathicity as observed in Fig. 1, shifted the WMF by
the addition of both SUV and LUV (Fig. 2B and D). Marked in-
creases in a-helix contents were observed upon binding to both
SUV and LUV (Fig. 3D). Taken together, at least in terms of mem-
brane curvature sensing, there exist some differences in the ami-
no acid distribution between the C-terminal peptide of apoA-I
and 18A peptide. Thus, we explored why membrane curvature
sensing differs in these two peptides by substituting some amino
acids both at the polar and non-polar faces of amphipathic
helices.Found: m/z (Calculated: M+H) hHi hlHi
2624.4 (2622.4) 0.451 0.410
2775.5 (2774.5) 0.296 0.455
2539.4 (2538.5) 0.480 0.437
2243.0 (2242.2) 0.309 0.565
2091.2 (2090.1) 0.488 0.457
2312.2 (2310.2) 0.319 0.574
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Fig. 1. Helical wheel representations of (A) apoA-I 220–241/F225W, (B) EKEK, (C) LL, (D) 18A, (E) 4S, and (F) 4F peptide. Solid and dashed circles show non-polar and polar
amino acid residues, respectively. Dotted lines in (A) and (D) indicate polar and non-polar interface.
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Fig. 2. (A, B) Fluorescence spectra of (A) apoA-I 220–241/F225W and (B) 18A peptides in the lipid-free state or in the presence of an excess amount of lipid. Solid line: lipid-
free, dotted line: with SUV, dashed line: with LUV. (C, D) Changes in WMF for (C) apoA-I 220–241 and (D) 18A-based peptides. ‘‘C-term’’ signiﬁes apoA-I 220–241/F225W
peptide. gray: lipid-free, open: with SUV, closed: with LUV.
512 M. Tanaka et al. / FEBS Letters 587 (2013) 510–5153.2. Effect of hydrophilic residues in membrane curvature sensing
Amphipathic lipid packing sensor (ALPS) motif has been shown
to recognize membrane curvature [2]. This motif differs frommany
amphipathic helices by having only hydroxylated Ser and Thr res-
idues and no basic amino acids at the polar face. Replacement ofhydroxylated residues by charged residues made the ALPS motif
peptide derived from ArfGAP1 less sensitive to membrane curva-
ture [12]. There are several hydroxylated residues at the polar face
of the C-terminal peptide of apoA-I, whereas no hydroxylated res-
idues exist in 18A peptide (Fig. 1A and D). Hence, we designed two
modiﬁed peptides with substitutions of hydrophilic residues at the
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Fig. 3. (A, B) CD spectra of (A) LL and (B) 4S peptides in the lipid-free state or in the presence of excess amount of lipid. Solid line: lipid-free, dotted line: with SUV, dashed
line: with LUV. (C, D) Changes in a-helix contents for (C) apoA-I 220–241 and (D) 18A-based peptides. ‘‘C-term’’ signiﬁes apoA-I 220–241/F225W peptide. Gray: lipid-free,
open: with SUV, closed: with LUV.
Table 2
Binding enthalpies generated upon titrating peptide into lipid vesicles.
Peptide Binding enthalpy (kcal/mol)
SUV LUV
apoA-I 220–241/F225W 7.3 ± 0.7 1.6 ± 0.2
EKEK 11.9 ± 1.1 0.9 ± 0.1
LL 5.7 ± 0.2 4.3 ± 1.0
18A 15.9 ± 0.3 4.9 ± 0.6
4S 13.1 ± 0.5 3.6 ± 0.3
4F 15.3 ± 0.3 6.9 ± 0.6
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rescence measurements revealed that replacement of Ser and Thr
residues in the original C-terminal peptide of apoA-I into charged
residues (referred to as EKEK) as well as substitutions of charged
residues in the original 18A peptide into Ser residues (referred to
as 4S) had no effect on membrane curvature sensing (Figs. 2C, D
and 3C, D). In CD measurements, such preferential binding was less
evident, especially in apoA-I EKEK peptide; only a slight increase in
a-helix content of apoA-I EKEK peptide upon binding to SUV was
observed.
In general, a-helix formation generates exothermic heat (nega-
tive enthalpy), which contribute to the free energy of binding [13].
Binding enthalpies are summarized in Table 2. Although the degree
of a-helix formation was comparable (Fig. 3B), the negative value
for binding enthalpy of 4S peptide to SUV was greater than that
to LUV, which is analogous to the present and previous results
using 18A peptide [14]. In contrast, heat generated by titrating
either apoA-I 220–241/F225W or EKEK peptide into LUV was
rather endothermic. Despite only a slight increase in a-helix con-
tent, apoA-I EKEK peptide exhibited large negative enthalpy upon
binding to SUV (Fig. 4A). From the CD results, it was postulated
that substitution of hydrophilic residues appears to affect the sec-
ondary structure in the lipid-free state. Comprehensively, charged
residues at the polar face are not involved in membrane curvaturesensing of the C-terminal peptide of apoA-I, as opposed to mem-
brane curvature sensing in BAR domains [15].
3.3. Effect of hydrophobic residues on membrane curvature sensing
Substitution of Leu to Phe residues on the non-polar face of a
class A amphipathic helical peptide altered the physicochemical
and biological properties [16,17]. The triple mutant of the ALPS
motif, in which three bulky hydrophobic residues at the non-polar
face were replaced simultaneously by Ala, did not bind liposomes
whatever the liposome size [18]. In fact, the C-terminal region of
mouse apoA-I, which contains Ala instead of aromatic residues at
the center of the non-polar face, shows signiﬁcantly reduced bind-
ing ability [19]. Therefore, we focused on the effect of hydrophobic
residues at the center of the non-polar face, especially of aromatic
residues (Fig. 1C and F). In the lipid-free state, replacement of Phe
and Tyr residues in the original C-terminal peptide of apoA-I into
Leu residues (referred to as LL) slightly shifted WMF to become
lower, probably due to self-association (Fig. 2C). Nevertheless,
apoA-I LL peptide signiﬁcantly shifted WMF even lower by the
addition of SUV. WMF of apoA-I LL peptide in the presence of
LUV seems to be shifted compared to that in the lipid-free state;
however, secondary structural changes of apoA-I LL peptide by
the addition of LUV were not observed in CD measurements
(Fig. 3A). It is conceivable that although hydrophobic interactions
between peptide and phospholipids occur, sufﬁcient enthalpic con-
tribution to the free energy of binding could not be acquired be-
cause of loss of helix formation on LUV. Corresponding
substitutions to Ala residues impaired binding even in the presence
of SUV (data not shown), as expected from the case in mouse apoA-
I. On the other hand, 18A peptide with two additional Phe residues
at the non-polar face (generally known as 4F) still bound to both
SUV and LUV, as indicated by Trp ﬂuorescence and CD measure-
ments (Figs. 2D and 3D).
Similar to other 18A-based peptides, binding of 4F peptide to
SUV generated large exothermic heat compared to less heat when
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Fig. 4. ITC curves of (A) EKEK and (B) 4F peptide (0.5 mg/ml) injected into SUV and LUV. Binding enthalpies were calculated by subtracting the dilution and dissociation heat
of the peptide.
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of a-helix formation to the thermodynamics of binding is not inﬂu-
enced by the curvature of lipid particles [20], other factors related
to the different packing densities modulate the enthalpic contribu-
tion. For example, penetration of a-helix into the LUV surface dis-
orders membrane packing, which yields positive enthalpy. Since
relatively minor perturbation occurs upon binding to a loosely
packed SUV surface, the enthalpic contribution generated from
a-helix formation dominates the thermodynamic process. Hydro-
phobic moment is one of the determinants for membrane parti-
tioning [21]. In fact, 18A-based peptides have higher hlHi values
than apoA-I 220–241 peptides (Table 1), although 4S and apoA-I
EKEK peptides have similar hlHi values, but also have highest
and lowest hHi values, respectively. Higher values in these param-
eters may cause relatively deep penetration of 18A-based peptides
into less curved vesicles, which disorders the PC acyl chains. In
addition, the size of the polar/non-polar angle could inﬂuence
the depth of penetration into membrane. Such differences might
affect the preferential binding of the peptides to a membrane with
a different curvature.
3.4. Physiological relevance of membrane curvature sensing of apoA-I
Membrane curvature is associated with membrane dynamics,
suchasmembrane fusion andvesiculation. It has beenproposed that
spontaneous solubilization of cellular membrane lipids occurs to
generateHDL particles by the concerted action of apoA-I andABCA1.
In this process, ABCA1 is assumed to modify the transbilayer distri-
bution of phospholipids such as phosphatidylserine (PS). However,
the addition of PS to LUV had no striking effect on apoA-I 220–
241/F225W peptide binding (data not shown), implying that the
asymmetric distribution of PS molecules preferentially to the outer
leaﬂet in cellular membrane may serve to enhance membrane cur-
vature [5,22]. ApoA-I is folded into two structural domains. The
unfolding stability of the N-terminal helix bundle domain of apoA-
I is correlated with its ability to solubilize membrane lipids [11].
The initial binding step of apoA-I molecule through the C-terminal
region appears to cause destabilization of the N-terminal helix bun-
dle. Consequently, the recognition ofmembrane curvature by the C-
terminal region of apoA-I triggers unfolding of the N-terminal helix
bundle domain to circumscribe HDL particles. On the other hand,
apoA-I was recently proposed to induce membrane curvature and
tubulate vesicles depending on the lipid composition [23]. Further
studies are required to examine the effect of lipid composition.
At this stage,we cannot determine the critical factors that govern
the membrane curvature sensing of apoA-I peptide. The relative
strength of hydrophobic and electrostatic membrane interactions
is considered to determinewhether helix-containing proteins sense
curvature [24]. From this viewpoint, the C-terminal region of apoA-Iis rigorously designed to recognize membrane curvature and to
strictly regulate lipid efﬂux function.
3.5. Implications for rational drug design mimicking apoA-I peptide
Small peptides based on the amphipathic a-helices of apoA-I
molecule are being developed for therapeutic use [25]. The present
results showing that 18A-based peptides, unlike apoA-I, bind to
lipids regardless of membrane curvature raise the possibility that
cholesterol efﬂux by these polypeptides occurs in a different region
in the cell; apoA-I selectively binds to a topically curved cell sur-
face generated by the action of ABCA1 molecule, whereas 18A pep-
tide binds to membrane irrespective of the curvature. In fact, some
18A-based peptides increased cholesterol efﬂux by an ABCA1-inde-
pendent mechanism [26,27]. Therefore, it is also probable that the
lipid compositions and sizes of HDL particles (i.e. quality) produced
by these polypeptides are different and affect the anti-atherogenic
properties of HDL particles. Elucidation of mechanisms of mem-
brane curvature sensing by amphipathic helical peptides may con-
tribute to the reﬁned design of therapeutic peptides for the
treatment of cardiovascular disease through a mechanism similar
to apoA-I molecule [28].
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